SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (4939)11/29/1997 4:12:00 PM
From: aknahow  Read Replies (3) | Respond to of 17367
 
Bob, help me out with expectations re the liver trials. I am not able to get a fel for what should be expected inthis area. In fact I thought they were running a bit behindn this area.



To: Robert K. who wrote (4939)11/29/1997 11:50:00 PM
From: Tharos  Read Replies (2) | Respond to of 17367
 
Bob,
It should have come as no surprise, considering menningitis, that some of the survivors had to have amputations.

I find it saddening that the Dr. chose to write bpi in the mannor he did, as opposed to saying "Hey everyone, we have a product that can save lives; however, its up to us physicians to correctly diagnose the disease as early as possible."

Tell the quack to go back to med school. ;-)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News